You are here:Home-Chemical Inhibitors & Agonists-Cell Cycle/DNA Damage-DNA/RNA Synthesis-Lurbinectedin
Lurbinectedin

Chemical Structure : Lurbinectedin

CAS No.: 497871-47-3

Lurbinectedin (PM01183, ZEPZELCA)

Catalog No.: PC-38616Not For Human Use, Lab Use Only.

Lurbinectedin (PM01183) is a marine-derived DNA minor groove covalent binder with potent in vitro and in vivo anti-tumour activity, inhibits RMG1 and RMG2 cell growth with IC50 of 1.25 nM and 1.16 nM, respectively.

Packing Price Stock Quantity
1 mg $278 In stock
5 mg $588 In stock
10 mg $898 In stock
25 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

Lurbinectedin (PM01183) is a marine-derived DNA minor groove covalent binder with potent in vitro and in vivo anti-tumour activity, inhibits RMG1 and RMG2 cell growth with IC50 of 1.25 nM and 1.16 nM, respectively.
Lurbinectedin (PM01183) inhibits growth of orthotopic primary graft of cisplatin-resistant epithelial ovarian cancer.
Lurbinectedin (PM01183) attenuates nucleotide excision repair (NER) and shows activity toward platinum-resistant cells.
Lurbinectedin (PM01183) inactivates EWS-FLI1 transcription factor by redistributing the protein within the nucleus to the nucleolus.

Physicochemical Properties

M.Wt 784.881
Formula C41H44N4O10S
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

Spiro[6,16-(epithiopropanoxymethano)-7,13-imino-12H-1,3-dioxolo[7,8]isoquino[3,2-b][3]benzazocine-20,1′-[1H]pyrido[3,4-b]indol]-19-one, 5-(acetyloxy)-2′,3′,4′,6,6a,7,9′,13,14,16-decahydro-8,14-dihydroxy-6′,9-dimethoxy-4,10,23-trimethyl-, (1′R,6R,6aR,7R,13S,14S,16R)-

References

1. Vidal A, et al. Clin Cancer Res. 2012 Oct 1;18(19):5399-411.

2. Soares DG, et al. Mol Cancer Ther. 2011 Aug;10(8):1481-9.

3. Elez ME, et al. Clin Cancer Res. 2014 Apr 15;20(8):2205-14.

4. Harlow ML, et al. Cancer Res. 2016 Nov 15;76(22):6657-6668.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: